TANG KEVIN
Transaction: 07/17/2026
BUY
Change
+50,945
Price
$3.52
Filing
07/20/2026
Type
BUY
Fulcrum Therapeutics, Inc.
FULC • Biotechnology
$3.85
▲ +0.01 (+0.26%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$204.81M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 33.5%Manageable debt level · 0.02Healthy liquidity · 27.4Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.85
Change0.26%
Market Cap$204.81M
52W Range2.83 - 15.74
Beta3.00
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.02
Current Ratio27.40
Quick Ratio27.40
Target$3.60
Price$3.85
Change0.26%
Market Cap$204.81M
52W Range2.83 - 15.74
Beta3.00
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.02
Current Ratio27.40
Quick Ratio27.40
Target$3.60
Target Upside-6.49%
Target Median$4.00
Target Range3.00 - 4.00
Volume78.03K
Avg Volume2.39M
EPS Surprise0.06
Investment DNA
How strong this company looks for long-term investors
54
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
86/100
Why this score▼
Positive revenue growth · 33.5%Manageable debt level · 0.02Healthy liquidity · 27.4Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-05
Low
$3.00
Mean
$3.60
Median
$4.00
High
$4.00
Insider Transactions
Recent executive and insider activity
TANG KEVIN
Transaction: 07/16/2026
BUY
Change
+116,671
Price
$3.56
Filing
07/20/2026
Type
BUY
TANG KEVIN
Transaction: 07/15/2026
BUY
Change
+107,377
Price
$3.56
Filing
07/15/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| TANG KEVIN | BUY | +50,945 | $3.52 | 07/17/2026 | 07/20/2026 |
| TANG KEVIN | BUY | +116,671 | $3.56 | 07/16/2026 | 07/20/2026 |
| TANG KEVIN | BUY | +107,377 | $3.56 | 07/15/2026 | 07/15/2026 |
| TANG KEVIN | BUY | +53,651 | $3.56 | 07/14/2026 | 07/15/2026 |
| TANG KEVIN | OTHER | 0 | Not reported | 07/13/2026 | 07/15/2026 |
| Ezekowitz Alan | BUY | +32,000 | $3.66 | 06/30/2026 | 07/02/2026 |
| Hill Colin | BUY | +32,000 | $3.66 | 06/30/2026 | 07/02/2026 |
| GERAGHTY JAMES A | BUY | +32,000 | $3.66 | 06/30/2026 | 07/02/2026 |
| King Rachel K. | BUY | +32,000 | $3.66 | 06/30/2026 | 07/02/2026 |
| Haviland Kate | BUY | +32,000 | $3.66 | 06/30/2026 | 07/02/2026 |
| Gould Robert J | BUY | +32,000 | $3.66 | 06/30/2026 | 07/02/2026 |
| Dorton Katina | BUY | +32,000 | $3.66 | 06/30/2026 | 07/02/2026 |
| Banks Sonja | BUY | +32,000 | $3.66 | 06/30/2026 | 07/02/2026 |
| Ezekowitz Alan | SELL | -18,000 | $3.65 | 06/26/2026 | 06/30/2026 |
| Lehrer-Graiwer Joshua | OTHER | 0 | Not reported | 04/23/2026 | 05/01/2026 |
| Lehrer-Graiwer Joshua | BUY | +64,000 | $8.08 | 04/23/2026 | 05/01/2026 |
| Sapir Alex | BUY | +650,000 | $10.72 | 02/02/2026 | 02/04/2026 |
| Tourangeau Greg | BUY | +57,000 | $10.72 | 02/02/2026 | 02/04/2026 |
| Gould Robert J | SELL | -15,000 | $10.72 | 02/02/2026 | 02/04/2026 |
| Oltmans Curtis Gale | BUY | +170,000 | $10.72 | 02/02/2026 | 02/04/2026 |